Exogenous NAD+ supplementation protects H9c2 cardiac myoblasts against hypoxia/reoxygenation injury via Sirt1-p53 pathway

Fundamental and Clinical Pharmacology

Volumn 28, Issue 2, 2014, Pages 180-189

  Liu, Ling ^a   Wang, Ping ^a   Liu, Xinwei ^a   He, Dongwei ^a   Liang, Canxin ^a   Yu, Ying ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cardioprotection; Hypoxia reoxygenation; Nicotinamide adenine dinucleotide; P53; Sirt1

Indexed keywords

LYSINE; NICOTINAMIDE ADENINE DINUCLEOTIDE; PROTEIN P53; SIRTUIN 1;

ACETYLATION; APOPTOSIS; ARTICLE; CELL DEATH; CELL LEVEL; CELL LINE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEACETYLATION; DRUG EFFECT; DRUG MECHANISM; HEART PROTECTION; HYPOXIA; MYOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REOXYGENATION; REPERFUSION INJURY;

APOPTOSIS; CARDIOPROTECTION; HYPOXIA/REOXYGENATION; NICOTINAMIDE ADENINE DINUCLEOTIDE; P53; SIRT1;

ANIMALS; APOPTOSIS; CELL CULTURE TECHNIQUES; CELL HYPOXIA; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MYOBLASTS, CARDIAC; MYOCARDIAL REPERFUSION INJURY; NAD; OXYGEN; RATS; SIGNAL TRANSDUCTION; SIRTUIN 1; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84895540674     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/fcp.12016     Document Type: Article

References (39)

1. Belaidi E., Beguin P.C., Levy P., Ribuot C., Godin-Ribuot D. Delayed myocardial preconditioning induced by cobalt chloride in the rat: HIF-1alpha and iNOS involvement. Fundam. Clin. Pharmacol. (2012) 26 454-462.
2. Puddu P.E., Salle L., Gerard J.L., Rouet R., Ducroq J. I(Ks) blockade in border zone arrhythmias from guinea-pig ventricular myocardium submitted to simulated ischemia and reperfusion. Fundam. Clin. Pharmacol. (2012) 26 445-453.
3. Frank A., Bonney M., Bonney S., Weitzel L., Koeppen M., Eckle T. Myocardial ischemia reperfusion injury: from basic science to clinical bedside. Semin. Cardiothorac. Vasc. Anesth. (2012) 16 123-132.
4. Becatti M., Taddei N., Cecchi C., Nassi N., Nassi P.A., Fiorillo C. SIRT1 modulates MAPK pathways in ischemic-reperfused cardiomyocytes. Cell. Mol. Life Sci. (2012) 69 2245-2260.
5. Di Lisa F., Menabo R., Canton M., Barile M., Bernardi P. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J. Biol. Chem. (2001) 276 2571-2575.
6. Hsu C.P., Oka S., Shao D., Hariharan N., Sadoshima J. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circ. Res. (2009) 105 481-491.
7. Satoh A., Stein L., Imai S. The role of mammalian sirtuins in the regulation of metabolism, aging, and longevity. Handb. Exp. Pharmacol. (2011) 206 125-162.
8. Houtkooper R.H., Pirinen E., Auwerx J. Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell Biol. (2012) 13 225-238.
9. Massudi H., Grant R., Guillemin G.J., Braidy N. NAD+ metabolism and oxidative stress: the golden nucleotide on a crown of thorns. Redox Rep. (2012) 17 28-46.
10. Xia W., Wang Z., Wang Q. et al. Roles of NAD(+)/NADH and NADP(+)/NADPH in cell death. Curr. Pharm. Des. (2009) 15 12-19.
11. Lappalainen Z. Sirtuins: a family of proteins with implications for human performance and exercise physiology. Res. Sports Med. (2011) 19 53-65.
12. Lu S.P., Kato M., Lin S.J. Assimilation of endogenous nicotinamide riboside is essential for calorie restriction-mediated life span extension in Saccharomyces cerevisiae. J. Biol. Chem. (2009) 284 17110-17119.
13. Mach J., Midgley A.W., Dank S., Grant R.S., Bentley D.J. The effect of antioxidant supplementation on fatigue during exercise: potential role for NAD+(H). Nutrients (2010) 2 319-329.
14. Eliasson M.J., Sampei K., Mandir A.S. et al. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat. Med. (1997) 3 1089-1095.
15. Pillai V.B., Sundaresan N.R., Kim G. et al. Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J. Biol. Chem. (2010) 285 3133-3144.
16. Wang S., Xing Z., Vosler P.S. et al. Cellular NAD replenishment confers marked neuroprotection against ischemic cell death: role of enhanced DNA repair. Stroke (2008) 39 2587-2595.
17. Won S.J., Choi B.Y., Yoo B.H. et al. Prevention of traumatic brain injury-induced neuron death by intranasal delivery of nicotinamide adenine dinucleotide. J. Neurotrauma (2012) 29 1401-1409.
18. Yang H., Yang T., Baur J.A. et al. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell (2007) 130 1095-1107.
19. Zhuo L., Fu B., Bai X. et al. NAD blocks high glucose induced mesangial hypertrophy via activation of the sirtuins-AMPK-mTOR pathway. Cell. Physiol. Biochem. (2011) 27 681-690.
20. Hsu C.P., Zhai P., Yamamoto T. et al. Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation (2010) 122 2170-2182.
21. Huang W., Shang W.L., Wang H.D., Wu W.W., Hou S.X. Sirt1 overexpression protects murine osteoblasts against TNF-alpha-induced injury in vitro by suppressing the NF-kappaB signaling pathway. Acta Pharmacol. Sin. (2012) 33 668-674.
22. Zhu X., Liu Q., Wang M. et al. Activation of Sirt1 by resveratrol inhibits TNF-alpha induced inflammation in fibroblasts. PLoS One (2011) 6 e27081.
23. Zhang Y., Wang J., Chen G., Fan D., Deng M. Inhibition of Sirt1 promotes neural progenitors toward motoneuron differentiation from human embryonic stem cells. Biochem. Biophys. Res. Commun. (2011) 404 610-614.
24. Hayashida S., Arimoto A., Kuramoto Y. et al. Fasting promotes the expression of SIRT1, an NAD+ -dependent protein deacetylase, via activation of PPARalpha in mice. Mol. Cell. Biochem. (2010) 339 285-292.
25. Lingaiah H.B., Natarajan N., Thamaraiselvan R., Srinivasan P., Periyasamy B.M. Myrtenal ameliorates diethylnitrosamine-induced hepatocarcinogenesis through the activation of tumor suppressor protein p53 and regulation of lysosomal and mitochondrial enzymes. Fundam. Clin. Pharmacol. (2012) [Epub ahead of print].
26. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell (1995) 80 293-299.
27. Ivanov G.S., Ivanova T., Kurash J. et al. Methylation-acetylation interplay activates p53 in response to DNA damage. Mol. Cell. Biol. (2007) 27 6756-6769.
28. Furukawa A., Tada-Oikawa S., Kawanishi S., Oikawa S. H2O2 accelerates cellular senescence by accumulation of acetylated p53 via decrease in the function of SIRT1 by NAD+ depletion. Cell. Physiol. Biochem. (2007) 20 45-54.
29. Hasegawa K., Yoshikawa K. Necdin regulates p53 acetylation via Sirtuin1 to modulate DNA damage response in cortical neurons. J. Neurosci. (2008) 28 8772-8784.
30. Pillai J.B., Isbatan A., Imai S., Gupta M.P. Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity. J. Biol. Chem. (2005) 280 43121-43130.
31. Sakao Y., Kato A., Tsuji T. et al. Cisplatin induces Sirt1 in association with histone deacetylation and increased Werner syndrome protein in the kidney. Clin. Exp. Nephrol. (2011) 15 363-372.
32. Vaziri H., Dessain S.K., Ng Eaton E. et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell (2001) 107 149-159.
33. Bruzzone S., Guida L., Zocchi E., Franco L., De Flora A. Connexin 43 hemi channels mediate Ca2+-regulated transmembrane NAD+ fluxes in intact cells. FASEB J. (2001) 15 10-12.
34. Song D., Liu X., Liu R., Yang L., Zuo J., Liu W. Connexin 43 hemichannel regulates H9c2 cell proliferation by modulating intracellular ATP and [Ca2+]. Acta Biochim. Biophys. Sin. (Shanghai) (2010) 42 472-482.
35. Pittelli M., Felici R., Pitozzi V. et al. Pharmacological effects of exogenous NAD on mitochondrial bioenergetics, DNA repair, and apoptosis. Mol. Pharmacol. (2011) 80 1136-1146.
36. Gerhart-Hines Z., Dominy J.E. Jr, Blattler S.M. et al. The cAMP/PKA pathway rapidly activates SIRT1 to promote fatty acid oxidation independently of changes in NAD(+). Mol. Cell (2011) 44 851-863.
37. Chen C.J., Yu W., Fu Y.C., Wang X., Li J.L., Wang W. Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1-FoxO1 pathway. Biochem. Biophys. Res. Commun. (2009) 378 389-393.
38. Langley E., Pearson M., Faretta M. et al. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J. (2002) 21 2383-2396.
39. Cai Y., Yu S.S., Chen S.R. et al. Nmnat2 protects cardiomyocytes from hypertrophy via activation of SIRT6. FEBS Lett. (2012) 586 866-874.